A Study of Tris-Hydroxymethyl Aminomethane (THAM) Versus Sodium Bicarbonate in Cardiac Surgical Patients

Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age21+
SponsorMayo Clinic

About this trial

The purpose of this research is to determine if two commonly used medications to treat metabolic acidosis in the setting of cardiac surgery, sodium bicarbonate and THAM, are equivalent.

Eligibility criteria

Qualifiers

* Cardiothoracic surgery with use of cardiopulmonary bypass

Presence of metabolic acidosis (defined as a base excess of <-5)

Minnesota Research Authorization

Disqualifiers

Non-cardiac surgery patients or cardiac surgery without cardiopulmonary bypass

Absence of metabolic acidosis (metabolic acidosis being defined as a base excess of <-5)

Pregnant patients

Prisoners

Trial design

Treatments tested in this trial

  • Sodium bicarbonate
  • Tris-hydroxymethyl Aminomethane

Treatment groups

250 Participants
are divided into 2 treatment groups

Sponsors and collaborators